Brind.

The University of Texas MD Anderson Cancer Center is collaborating with Quest Diagnostics on the development of a new MCaST blood test.

1 report, 1 independent Updated Jul 14
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

The University of Texas MD Anderson Cancer Center is collaborating with Quest Diagnostics on the development of a new MCaST blood test.

Who's involved

What this event is mainly about
The University of Texas MD Anderson Cancer CenterQuest Diagnostics

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped
  • Insider MonkeyQuest Diagnostics (DGX) Develops MCaST Blood Test with MD Anderson Cancer Center Quest Diagnostics Incorporated (NYSE:DGX) is one of the 7 most undervalued pot stocks to buy according to analysts. On